Kimberly M. Kelly , PhD, MS

Associate Professor, HSOR PhD Program

Organization:

West Virginia University School of Pharmacy

Department:

Pharmaceutical Systems & Policy

Classification:

Faculty

Member

Organization:

West Virginia University WVU Cancer Institute

Department:

WVU Cancer Institute Research Programs

Classification:

Faculty

• PhD, Psychology, Rutgers, The State University of New Jersey, 2000
• MS, Genetic Counseling, Indiana University, School of Medicine, Indianapolis, IN, 2002

Ten Most Recent:
Car seat safety: typologies of protective health and safety behaviors for mothers in West Virginia.
Thornton JD, Deb A, Murray PJ, Kelly KM.
Matern Child Health J. 2017; 21(2): 326-334.
PMC5247407

Cancer risk information sharing: the experience of individuals receiving genetic counseling for BRCA1/2 mutations.
Chopra I, Kelly KM.
J Health Commun. 2017; 22(2): 143-152.

Cancer type and risk of newly diagnosed depression among elderly Medicare beneficiaries with incident breast, colorectal, and prostate cancers.
Alwhaibi M, Sambamoorthi U, Madhavan SS, Bias TK, Kelly KM, Walkup J.
J Natl Compr Canc Netw. 2017; 15(1): 46-55.

Depression treatment among elderly Medicare beneficiaries with incident cases of cancer and newly diagnosed depression.
Alwhaibi M, Madhavan SS, Bias TK, Kelly KM, Walkup J, Sambamoorthi U.
Psychiatr Serv. 2017.

Impact of genetic counseling and testing on altruistic motivations to test for BRCA1/2: a longitudinal study.
Garg R, Vogelgesang J, Kelly KM.
J Genet Couns. 2016; 25(3): 572-582.
PMC4870135

Type of multimorbidity and patient-doctor communication and trust among elderly Medicare beneficiaries.
Garg R, Shen C, Sambamoorthi N, Kelly KM, Sambamoorthi U.
Int J Family Med. 2016; 2016: 8747891.
PMC5069353

Improving family history collection.
Kelly KM, Shedlosky-Shoemaker R, Atkins E, Tworek C, Porter K.
J Health Commun. 2015; 20(4): 445-452.

Cervical cancer worry and screening among Appalachian women.
Kelly KM, Schoenberg NE, Wilson TD, Atkins E, Dickinson SL, Paskett ED.
J Primary Prev. 2015; 36(2): 79-92.
PMC4348207

Genetic counseling content: How does it impact behavior?
Kelly KM, Ellington L, Schoenberg NE, Jackson T, Dickinson SL, Porter K, Leventhal H, Andrykowski MA.
J Behav Med. 2015; 38(5): 766-776.
PMC4478279

Breastfeeding: an unknown factor to reduce heart disease risk among breastfeeding women.
Kelly KM, Chopra I, Dolly B.
Breastfeed Med. 2015; 10: 442-447.
 

BIOSKETCH

Dr. Kimberly Kelly is an Associate Professor in the Department of Pharmaceutical Systems and Policy in the School of Pharmacy and the West Virginia University Cancer Institute. She received her MS (1998) and PhD (2000) in social and health psychology from Rutgers University, her MS (2002) in genetic counseling from Indiana University, and completed a post-doctoral fellowship in cancer control and behavioral science at the University of Kentucky (2002-2004). Before joining West Virginia University, Dr. Kelly was a member of the Department of Molecular Virology, Immunology, and Medical Genetics, and was also affiliated with the Department of Psychology, Health Behavior and Health Promotion in the College of Public Health, the Primary Care Research Institute, and the Comprehensive Cancer Center at The Ohio State University.

Three overlapping themes emerge from Dr. Kelly’s research: (1) cancer risk perception/communication, (2) health behavior (e.g., cancer screening, genetic testing), and (3) elevated risk populations (e.g., Appalachians, those with a family history of cancer). Her work relies on behavioral theory from psychology (health, social, cognitive), as well as communication and information sciences. She mixes qualitative and quantitative methods, utilizing clinic-based and community-based approaches. Most of her research has focused on how risk is communicated in the context of cancer genetic counseling and how risk perceptions differ from objective estimates of risk. She also examines the role of risk perception in cancer screening. Through her research, Dr. Kelly hopes to understand how best to enhance appropriate decision-making about health behaviors in elevated risk populations to accomplish optimal health outcomes.

Program 2: Breast Cancer